HER3 mutations are also reported to be a potential mechanism of tumor immune escape, as ectopic expression of mutated HER3 upregulated the expression of programmed-death ligand 1 by gallbladder carcinoma cells [14]. Here, ERBB3 is linked to neoplasm.